43769 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 11
16:53 UTC
|
MDLN
Medline
|
◎ Target | Ivan Feinseth ★★★☆☆ #1312 | Buy | $62.00→ $55.00-11.3% |
|
Aug 11
16:53 UTC
|
LKFT
Lakefront Biotherapeutics American Depositary Shares
|
◎ Target | Judah Frommer ★★☆☆☆ #2534 | Equal Weight | $30.00→ $26.00-13.3% |
|
Aug 11
16:53 UTC
|
JAZZ
Jazz Pharmaceuticals
|
◎ Target | Jeffrey Hung not yet tracked | Overweight | $280.00→ $283.00+1.1% |
|
Aug 11
16:53 UTC
|
INTU
Intuit
|
◎ Target | Jared Levine ★★☆☆☆ #2474 | Hold | $304.00→ $328.00+7.9% |
|
Aug 11
16:53 UTC
|
IMMX
Immix Biopharma
|
◎ Target | Judah Frommer ★★☆☆☆ #2534 | Overweight | $20.00→ $19.00-5.0% |
|
Aug 11
16:53 UTC
|
HIMS
Hims & Hers Health
|
◎ Target | Craig Hettenbach ★★★☆☆ #1929 | Equal Weight | $21.00→ $28.00+33.3% |
|
Aug 11
16:53 UTC
|
HIMS
Hims & Hers Health
|
◎ Target | Jonna Kim ★★★☆☆ #974 | Hold | $25.00→ $30.00+20.0% |
|
Aug 11
16:53 UTC
|
GDRX
GoodRx
|
◎ Target | Charles Rhyee ★★★☆☆ #1300 | Buy | $4.00→ $5.00+25.0% |
|
Aug 11
16:53 UTC
|
DH
Definitive Healthcare
|
◎ Target | Craig Hettenbach ★★★☆☆ #1929 | Equal Weight | $2.50→ $1.50-40.0% |
|
Aug 11
16:53 UTC
|
CODI
Compass Diversified
|
◎ Target | Lance Vitanza ★★★☆☆ #1331 | Buy | $12.50→ $18.00+44.0% |
|
Aug 11
16:53 UTC
|
COAG
Hemab Therapeutics
|
◎ Target | Emily Bodnar ★★★☆☆ #2067 | Buy | $52.00→ $60.00+15.4% |
|
Aug 11
16:53 UTC
|
CEVA
Ceva
|
◎ Target | Joshua Buchalter ★★★☆☆ #1894 | Buy | $55.00→ $45.00-18.2% |
|
Aug 11
16:53 UTC
|
CBLL
CeriBell
|
◎ Target | William Plovanic ★★★☆☆ #2028 | Buy | $25.00→ $26.00+4.0% |
|
Aug 11
16:53 UTC
|
CAMT
Camtek
|
◎ Target | Shane Brett not yet tracked | Equal Weight | $167.00→ $165.00-1.2% |
|
Aug 11
16:53 UTC
|
BBIO
BridgeBio Pharma
|
◎ Target | Sean Laaman ★★★☆☆ #2030 | Overweight | $98.00→ $97.00-1.0% |
|
Aug 11
16:53 UTC
|
BBIO
BridgeBio Pharma
|
◎ Target | Tyler Van Buren ★★★★☆ #895 | Buy | $95.00→ $110.00+15.8% |
|
Aug 11
16:53 UTC
|
AXSM
Axsome Therapeutics
|
◎ Target | Sean Laaman ★★★☆☆ #2030 | Equal Weight | $242.00→ $251.00+3.7% |
|
Aug 11
16:53 UTC
|
AURA
Aura Biosciences
|
◎ Target | Andres Y. Maldonado ★★☆☆☆ #2510 | Buy | $24.00→ $18.00-25.0% |
|
Aug 11
15:53 UTC
|
ZG
Zillow Group
|
◎ Target | Dae Lee ★★★☆☆ #1754 | Overweight | $76.00→ $62.00-18.4% |
|
Aug 11
15:53 UTC
|
Z
Zillow Group
|
◎ Target | Dae Lee ★★★☆☆ #1754 | Overweight | $76.00→ $62.00-18.4% |
|
Aug 11
15:53 UTC
|
WBTN
WEBTOON Entertainment
|
◎ Target | Dae Lee ★★★☆☆ #1754 | Neutral | $11.00→ $10.00-9.1% |
|
Aug 11
15:53 UTC
|
VTR
Ventas
|
◎ Target | Juan Sanabria not yet tracked | Outperform | $105.00→ $107.00+1.9% |
|
Aug 11
15:53 UTC
|
VKTX
Viking Therapeutics
|
◎ Target | Hardik Parikh ★★☆☆☆ #2636 | Overweight | $75.00→ $65.00-13.3% |
|
Aug 11
15:53 UTC
|
URG
Ur Energy
|
◎ Target | Heiko F. Ihle not yet tracked | Buy | $2.30→ $2.20-4.3% |
|
Aug 11
15:53 UTC
|
UPWK
Upwork
|
◎ Target | Brad Erickson ★★☆☆☆ #2674 | Sec→ r Perform | $9.00→ $8.00-11.1% |
|
Aug 11
15:53 UTC
|
TGT
Target
|
◎ Target | Kelly Bania ★★★☆☆ #1385 | Market Perform | $130.00→ $150.00+15.4% |
|
Aug 11
15:53 UTC
|
SNDX
Syndax Pharmaceuticals
|
◎ Target | Anupam Rama ★★★☆☆ #1798 | Overweight | $44.00→ $40.00-9.1% |
|
Aug 11
15:53 UTC
|
SMR
NuScale Power
|
◎ Target | Christopher Dendrinos not yet tracked | Sec→ r Perform | $14.00→ $10.00-28.6% |
|
Aug 11
15:53 UTC
|
SEPN
Septerna
|
◎ Target | Seamus Fernandez ★★★☆☆ #1949 | Buy | $45.00→ $51.00+13.3% |
|
Aug 11
15:53 UTC
|
RPD
Rapid7
|
◎ Target | Patrick Colville ★★★☆☆ #1252 | Sec→ r Perform | $7.00→ $10.15+45.0% |
|
Aug 11
15:53 UTC
|
ONON
ON
|
◎ Target | Tom Nikic ★★★☆☆ #1868 | Buy | $45.00→ $37.00-17.8% |
|
Aug 11
15:53 UTC
|
NIQ
NIQ Global Intelligence
|
◎ Target | Ashish Sabadra ★★★☆☆ #2138 | Outperform | $13.00→ $17.00+30.8% |
|
Aug 11
15:53 UTC
|
NABL
N-able
|
◎ Target | Patrick Colville ★★★☆☆ #1252 | Sec→ r Perform | $5.75→ $3.65-36.5% |
|
Aug 11
15:53 UTC
|
NABL
N-able
|
◎ Target | Keith Bachman ★★★☆☆ #1566 | Market Perform | $6.00→ $3.75-37.5% |
|
Aug 11
15:53 UTC
|
LKFT
Lakefront Biotherapeutics American Depositary Shares
|
◎ Target | Brian Abrahams ★★☆☆☆ #2650 | Sec→ r Perform | $28.00→ $26.00-7.1% |
|
Aug 11
15:53 UTC
|
FUN
Six Flags Entertainment
|
◎ Target | Matthew Boss ★★★☆☆ #1257 | Neutral | $26.00→ $22.00-15.4% |
|
Aug 11
15:53 UTC
|
FERG
Ferguson
|
◎ Target | Mike Dahl not yet tracked | Outperform | $281.00→ $290.00+3.2% |
|
Aug 11
15:53 UTC
|
DRTS
Alpha Tau Medical
|
◎ Target | Yi Chen ★★★☆☆ #1720 | Buy | $15.00→ $16.00+6.7% |
|
Aug 11
15:53 UTC
|
BHVN
Biohaven
|
◎ Target | Leonid Timashev ★★☆☆☆ #2318 | Outperform | $22.00→ $23.00+4.5% |
|
Aug 11
15:53 UTC
|
AXSM
Axsome Therapeutics
|
◎ Target | Leonid Timashev ★★☆☆☆ #2318 | Outperform | $304.00→ $297.00-2.3% |
|
Aug 11
15:53 UTC
|
AXSM
Axsome Therapeutics
|
◎ Target | Yatin Suneja ★★★☆☆ #1119 | Buy | $260.00→ $275.00+5.8% |
|
Aug 11
15:53 UTC
|
AMPY
Amplify Energy
|
◎ Target | Subash Chandra ★★★★☆ #353 | Buy | $11.00→ $9.00-18.2% |
|
Aug 11
14:52 UTC
|
VOYA
Voya Financial
|
◎ Target | Pablo Singzon ★★★☆☆ #1772 | Neutral | $105.00→ $109.00+3.8% |
|
Aug 11
14:52 UTC
|
SPT
Sprout Social
|
◎ Target | Raimo Lenschow ★★★☆☆ #1694 | Overweight | $9.00→ $12.00+33.3% |
|
Aug 11
14:52 UTC
|
RPD
Rapid7
|
◎ Target | Saket Kalia ★★★☆☆ #1655 | Underweight | $6.50→ $12.00+84.6% |
|
Aug 11
14:52 UTC
|
RPD
Rapid7
|
◎ Target | Rob Owens ★★★★☆ #603 | Neutral | $8.00→ $12.00+50.0% |
|
Aug 11
14:52 UTC
|
RPD
Rapid7
|
◎ Target | Brian Essex ★★★☆☆ #2038 | Neutral | $7.00→ $12.00+71.4% |
|
Aug 11
14:52 UTC
|
RGA
Reinsurance Group of America
|
◎ Target | Pablo Singzon ★★★☆☆ #1772 | Overweight | $286.00→ $293.00+2.4% |
|
Aug 11
14:52 UTC
|
RCKT
Rocket Pharmaceuticals
|
◎ Target | Yun Zhong ★★☆☆☆ #2701 | Outperform | $16.00→ $15.00-6.2% |
|
Aug 11
14:52 UTC
|
QFIN
Qfin
|
◎ Target | Katherine Lei ★★★★★ #147 | Neutral | $14.50→ $13.50-6.9% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.